Skip to main content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting No. 3
Monday, March 7, 2016, 3:30 p.m. to 5:40 p.m.
Video recorded session
Presiding
Bill Casey, Chair (Liberal)

Expand AllCollapse All
• Tom Kmiec for Hon. K. Kellie Leitch (Conservative)
• Bryan May for John Oliver (Liberal)
• Kamal Khera (Liberal)
Library of Parliament
• Karin Phillips, Analyst
Briefing on the Zika Virus Outbreak
Canadian Blood Services
• Dr. Dana Devine, Chief Medical and Scientific Officer
• Dr. Graham Sher, Chief Executive Officer
Public Health Agency of Canada
• Matthew Gilmour, Scientific Director General, National Microbiology Laboratory, Infectious Disease Prevention and Control Branch
• Dr. Gregory Taylor, Chief Public Health Officer
Pursuant to Standing Order 108(2) and the motion adopted on Wednesday, February 17, 2016, the Committee proceeded to a briefing session on the Zika virus outbreak.

Dr. Gregory Taylor and Dr. Graham Sher made statements and, with Matthew Gilmour and Dr. Dana Devine, answered questions.

At 5:01 p.m., the sitting was suspended.

At 5:11 p.m., the sitting resumed.

Committee Business
The Committee proceeded to the consideration of matters related to Committee business.

It was agreed, — That based on the evidence received by the Committee in relation to its briefing on the Zika Virus on March 7, 2016, the analysts prepare a Summary of Evidence.

The Chair presented the First Report from the Subcommittee on Agenda and Procedure which read as follows:

Your Subcommittee met on Monday, February 22, 2016 and recommends that the top priority items for the Committee be:

1. To undertake a study on the development of a national Pharmacare program as an insured service for Canadians under the Canada Health Act and to report the findings to the House;

2. To request a briefing from the Canadian Blood Services on the “Call to Action” report and on the status of Canada’s organ and tissue donation procurement system; and that the Minister of Health be requested to provide a response to the Committee on the findings of the “Call to Action” report and the actions taken to address the recommendations of the report;

3. To undertake a study on home care and palliative care and to report the findings to the House;

4. To undertake a study on the status of Aboriginal health and to report the findings to the House;

5. To undertake a study on the status of antibiotic resistance and to report the findings to the House.

Debate arose thereon.

After debate, it was agreed — That the First Report of the Subcommittee on Agenda and Procedure be concurred in.

It was agreed, — That, in relation to the study on the development of a national Pharmacare program as an insured service for Canadians under the Canada Health Act, the meeting of April 11, 2016, be dedicated to hearing officials from the Health Department; that six meetings be dedicated to the hearing of witnesses; and that the members of the Committee submit to the Clerk of the Committee, by Friday, March 11, 2016, their prioritized lists of witnesses.

At 5:40 p.m., the Committee adjourned to the call of the Chair.



David Gagnon
Clerk of the Committee